The United States transfection technologies market size reached US$ 359 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 557 Million by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028. More Info:- https://www.imarcgroup.com/united-states-transfection-technologies-market

1. United States Transfection
Technologies Market
Research and Forecast
Report 2023-2028
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "United States
Transfection Technologies Market: Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2023-2028," the United States transfection
technologies market size reached US$ 359 Million in 2022.
Transfection technology is a vital laboratory technique in molecular biology and
biotechnology research. It introduces exogenous genetic material into
eukaryotic cells, such as deoxyribonucleic acid (DNA) or ribonucleic acid
(RNA), enabling scientists to study gene function, protein expression, cellular
processes, and genetic modifications.
It is utilized in various scientific fields, including gene function studies, protein
expression for research or therapeutic purposes, disease research, cell line
development, and drug screening. Transfection technology is applied to various
cell types and biological systems allowing researchers to customize
experiments by selecting specific genes or genetic elements to introduce into
cells, and the technique offers both temporary and stable genetic modifications
depending on the method used. The speed and efficiency of transfection allows
for rapid manipulation of cell genetics, yielding quicker results than other
genetic engineering approaches.
Request for a PDF sample of this report: https://www.imarcgroup.com/united-
states-transfection-technologies-market/requestsample

4. Report Description
United States Transfection Technologies Market Trends:
The increasing demand for transfection technology as the understanding of genetics and molecular biology increases is
one of the major factors driving the market growth. Additionally, the growing application of transfection technologies as
researchers and biotechnologists rely on it to study gene function, protein expression, and cellular processes, leading to
significant breakthroughs in various scientif ic fields, is creating a positive outlook for the market. Moreover, the rising
prevalence of infectious diseases in the US, such as bacterial infections, necessitates the development of effective
antibiotics enabling the introduction of antimicrobial genes or genetic constructs into cells to combat drug-resistant
pathogens, is positively impacting the market growth. In addition to this, the growing application of these technologies for
modif ying cells before reintroducing them into patients, enhancing the therapeutic potential with cell-based therapies,
such as CAR-T cell therapy, is supporting the market growth. Furthermore, rapid technological advancements in
transfection methods and delivery systems that have made the process more efficient, reliable, and accessible are
propelling the market growth. In line with this, the increasing utilization of these technologies in delivering therapeutic
genes and molecules to target cancer cells and supporting precision medicine approaches tailored to individual patient
prof iles are providing remunerative growth opportunities. Besides this, the growing product popularity in the production of
recombinant proteins used in therapeutic applications is favoring the market growth. Apart from this, the widespread
application of transfection technology in the agricultural sector to engineer crops and improve their traits, such as
disease resistance, nutritional content, and yield, and the increasing global demand for sustainable and enhanced crop
production is providing a considerable boost to the market growth.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/united-states-transfection-
technologies-market

5. Report
Segmentation
Breakup by Product Type:
• Reagent
• Instrument
• Others
Breakup by Application:
• Therapeutic Delivery
• Bio-Medical Research
• Protein Production
• Others
Breakup by Transfection Method:
• Lipofection
• Electroporation
• Nucleofection
• Cotransfection
• Cationic Lipid Transfection
• In-Vivo Transfection

6. Report
Segmentation
• Others
Breakup by Technology:
• Physical Transfection
• Biochemical Based Transfection
• Viral-Vector Based Transfection
Breakup by End User:
• Research Centers and Academic Institutes
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Others
Breakup by Region:
• Northeast
• Midwest
• South
• West

7. Key Questions
Answered in
the Report
How has the United States transfection technologies market
performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the United States
transfection technologies market?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the transfection
method?
What is the breakup of the market based on the technology?

8. Key Questions
Answered in
the Report
What is the breakup of the market based on the end user?
What is the breakup of the market based on the transfection
method?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the
industry?
What is the structure of the United States transfection
technologies market and who are the key players?
What is the degree of competition in the industry?

9. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 United States Transfection Technologies Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Reagent
6.1.1 Market Trends
6.1.2 Mark et Forecast
6.2 Instrument
6.2.1 Market T rends
6.2.2 Market Forecast
6.3 Others
6.3.1 Mark et T rends
6.3.2 Mark et Forecast
7 Market Breakup by Application

10. Table of
Contents
7.1 T herapeutic Delivery
7.1.1 Mark et Trends
7.1.2 Mark et Forecast
7.2 Bio-Medical Research
7.2.1 Mark et Trends
7.2.2 Mark et Forecast
7.3 Protein Production
7.3.1 Mark et Trends
7.3.2 Mark et Forecast
7.4 Others
7.4.1 Mark et Trends
7.4.2 Mark et Forecast
8 Market Breakup by Transfection Method
8.1 Lipof ection
8.1.1 Market Trends
8.1.2 Mark et Forecast
8.2 Electroporation
8.2.1 Mark et Trends
8.2.2 Mark et Forecast
8.3 Nucleofection
8.3.1 Mark et Trends
8.3.2 Mark et Forecast
8.4 Cotransfection
8.4.1 Market Trends
8.4.2 Mark et Forecast
8.5 Cationic Lipid T ransfection
8.5.1 Mark et Trends
8.5.2 Mark et Forecast
For more information, visit :
https://www.imarcgroup.com/united -states-transfection-
technologies-market/toc

11. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

12. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com